Company news

Rohto Pharmaceutical Co., Ltd. news in 2026

Rohto Pharmaceutical Co., Ltd.'s news releases, calls and decks from 2026, newest first.

View company

Notice Regarding Partial Corrections to “Medium- to Long-Term Growth Strategy 2026”

October 5, 2026

Medium- to Long-Term Growth Strategy 2026,October 5, 2026

October 5, 2026

Medium- to Long-Term Growth Strategy 2026

October 1, 2026

Management Strategy Briefing

October 1, 2026

バージャー病、膠原病により生じる難治性虚血性（非動脈硬化性）下肢潰瘍に対するRE-01細胞治療の第II相医師主導治験を開始

September 15, 2026

Notice Regarding the Status of Repurchase of Shares and Completion of Repurchase

September 15, 2026

Ono Pharma Enters into a Drug Discovery Partnership with Aitia in Neurological Diseases

September 1, 2026

Notice Regarding the Status of Repurchase of Shares

September 1, 2026

Notice Regarding Voluntary Recall of Vietnamese-Made Eye Drops in the United States

August 10, 2026

Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2027 (Three Months Ended June 30, 2026)

August 6, 2026

Decks in 2026